[{"address1": "2 Corporate Drive", "address2": "First Floor", "city": "South San Francisco", "state": "CA", "zip": "94080", "country": "United States", "phone": "650 239 2030", "website": "https://www.sentibio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Senti Biosciences, Inc. operates as a preclinical biotechnology company that develops next-generation cell and gene therapies engineered with its gene circuit platform technologies for various diseases. Its lead product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated OR+NOT off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma. It also develops SENTI-401, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate colorectal cancer/CRC cells. In addition, the company develops Tumor-Associated Antigen and Protective Antigen Paired Discovery Platform to select and validate NOT GATE antigen candidates and identify tumor-associated antigens in cancer cells. The company has a strategic collaboration with Celest Therapeutics (Shanghai) Co. Ltd for the clinical development of SENTI-301A to treat solid tumors. Senti Biosciences, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.", "fullTimeEmployees": 48, "companyOfficers": [{"maxAge": 1, "name": "Dr. Timothy K. Lu M.D., Ph.D.", "age": 43, "title": "Co-Founder, CEO & Director", "yearBorn": 1981, "fiscalYear": 2024, "totalPay": 630788, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Kanya  Rajangam M.D., Ph.D.", "age": 50, "title": "President, Head of Research & Development and Chief Medical Officer", "yearBorn": 1974, "fiscalYear": 2024, "totalPay": 528545, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. James J. Collins Ph.D.", "age": 57, "title": "Scientific Co-Founder, Chairperson of Scientific Advisory Board & Independent Director", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 43875, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Yvonne  Li M.B.A.", "age": 63, "title": "Consultant", "yearBorn": 1961, "fiscalYear": 2024, "totalPay": 547540, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Wilson  Wong Ph.D.", "title": "Scientific Co-Founder & Member of Scientific Advisory Board", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jay  Cross", "age": 53, "title": "Chief Financial Officer", "yearBorn": 1971, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Faraz  Siddiqui", "title": "Senior Vice President of Technical Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert H. Cutler J.D.", "age": 56, "title": "Senior VP & Head of Legal Affairs", "yearBorn": 1968, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Thomas P. Chung", "title": "Vice President of Strategic Finance & Corporate Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Dee Olomajeye Dragon", "title": "VP of People & Culture Strategy & Head of Administrative Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 3.65, "open": 3.96, "dayLow": 3.6101, "dayHigh": 3.96, "regularMarketPreviousClose": 3.65, "regularMarketOpen": 3.96, "regularMarketDayLow": 3.6101, "regularMarketDayHigh": 3.96, "payoutRatio": 0.0, "beta": 2.528, "forwardPE": -4.866667, "volume": 19228, "regularMarketVolume": 19228, "averageVolume": 60644, "averageVolume10days": 39830, "averageDailyVolume10Day": 39830, "bid": 2.76, "ask": 4.8, "bidSize": 2, "askSize": 2, "marketCap": 17627530, "fiftyTwoWeekLow": 1.52, "fiftyTwoWeekHigh": 16.94, "priceToSalesTrailing12Months": "Infinity", "fiftyDayAverage": 3.95982, "twoHundredDayAverage": 3.167055, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 40621556, "profitMargins": 0.0, "floatShares": 1658749, "sharesOutstanding": 4829460, "sharesShort": 70424, "sharesShortPriorMonth": 103785, "sharesShortPreviousMonthDate": 1738281600, "dateShortInterest": 1740700800, "sharesPercentSharesOut": 0.0146, "heldPercentInsiders": 2.79353, "heldPercentInstitutions": 1.7875999, "shortRatio": 1.99, "shortPercentOfFloat": 0.0174, "impliedSharesOutstanding": 5113930, "bookValue": 3.487, "priceToBook": 1.0467451, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -70868000, "trailingEps": -15.59, "forwardEps": -0.75, "lastSplitFactor": "1:10", "lastSplitDate": 1721260800, "enterpriseToEbitda": -0.767, "52WeekChange": -0.17045456, "SandP52WeekChange": 0.07465422, "quoteType": "EQUITY", "currentPrice": 3.65, "targetHighPrice": 12.0, "targetLowPrice": 12.0, "targetMeanPrice": 12.0, "targetMedianPrice": 12.0, "recommendationKey": "none", "numberOfAnalystOpinions": 1, "totalCash": 10836000, "totalCashPerShare": 2.361, "ebitda": -52964000, "totalDebt": 34709000, "quickRatio": 1.326, "currentRatio": 1.918, "totalRevenue": 0, "debtToEquity": 217.013, "revenuePerShare": 0.0, "returnOnAssets": -0.37507, "returnOnEquity": -1.43269, "grossProfits": -35706000, "freeCashflow": 2945375, "operatingCashflow": -34930000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "SNTI", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "regularMarketTime": 1742410500, "exchange": "NCM", "messageBoardId": "finmb_538838857", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "shortName": "Senti Biosciences, Inc.", "longName": "Senti Biosciences, Inc.", "regularMarketChangePercent": 0.0, "regularMarketPrice": 3.65, "earningsTimestampStart": 1731618323, "earningsTimestampEnd": 1731618323, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -15.59, "epsForward": -0.75, "epsCurrentYear": -14.54, "priceEpsCurrentYear": -0.25103164, "fiftyDayAverageChange": -0.30981994, "fiftyDayAverageChangePercent": -0.078240916, "twoHundredDayAverageChange": 0.4829452, "twoHundredDayAverageChangePercent": 0.15249032, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1622035800000, "marketState": "REGULAR", "regularMarketChange": 0.0, "regularMarketDayRange": "3.6101 - 3.96", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 60644, "fiftyTwoWeekLowChange": 2.13, "fiftyTwoWeekLowChangePercent": 1.4013159, "fiftyTwoWeekRange": "1.52 - 16.94", "fiftyTwoWeekHighChange": -13.290001, "fiftyTwoWeekHighChangePercent": -0.7845337, "fiftyTwoWeekChangePercent": -17.045456, "displayName": "Senti Biosciences", "trailingPegRatio": null, "__fetch_time": "2025-03-19"}]